Evaluation of the Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Evaluation of the Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
This is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188) relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia.
Inclusion Criteria:
Exclusion Criteria:
Vijaywada, ANDH PRAD 520002, India
Tirupati, Tamil Nadu 517507, India
Lembah Pantai, Kuala Lumpur 59100, Malaysia
Kyiv, Kyiv Oblast 04080, Ukraine
Kyiv, Kyiv Oblast 04655, Ukraine